Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
acid, adagrasib, ADP, antagonist, Area, Asian, background, BCMA, Blinded, Breakthrough, Bulgaria, ccRCC, clear, cohort, concentration, Croatia, Czechia, Depository, disability, ENLIGHTEN, Finnish, fulfillment, Halozyme, hepatocellular, Hungary, hyaluronidase, hydrolase, idiopathic, IIA, iiib, imputation, instance, intracranial, IPF, Italy, juvenile, killer, Krazati, lease, left, LianBio, LifePoint, Lithuania, living, LTE, lysophosphatidic, Mayo, Mirati, mutation, Myelodysplastic, Mylan, Natco, noninferior, noninferiority, nonresponder, outflow, overturned, parallel, PASI, pathologic, payout, people, perioperative, permanent, Poland, population, Portugal, Portuguese, PPF, promising, pulmonary, pursue, randomized, readout, recall, recombinant, renal, ribose, robust, serum, sham, sideroblast, Slovakia, Spain, Spanish, steady, stimulating, subscription, surgery, Switzerland, trough, unfavorable, Unregistered, ventricular, weighted, worsening, worth
Removed:
add, adding, AML, bio, Biocon, Certificate, comply, compulsivity, correct, de, effectively, eligibility, employed, ESA, eventually, extension, HCC, intervene, inventorship, JIA, launch, likewise, NKT, NVAF, partner, petition, Pfizer, positive, preempted, pretrial, prevented, PsA, RBC, remained, ruled, treating
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view